| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Zhao-You Tang | |
| Lun-Xiu Qin | |||
| P2860 | cites work | CD44 cell adhesion molecules | Q24568164 |
| Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis | Q27478444 | ||
| Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy | Q27824765 | ||
| The Ki-67 protein: from the known and the unknown | Q28143714 | ||
| RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs | Q31739337 | ||
| Clinical implications of circulating angiogenic factors in cancer patients | Q31960701 | ||
| Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas. | Q33942263 | ||
| Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis | Q34070339 | ||
| Circulating DNA in plasma or serum. | Q34144929 | ||
| The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma | Q34172090 | ||
| p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. | Q34174341 | ||
| Circulating angiogenesis regulators in cancer patients. | Q34209406 | ||
| Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations. | Q34271829 | ||
| beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. | Q34302259 | ||
| Hepatocellular carcinoma--cause, treatment and metastasis | Q34512068 | ||
| Moving toward an understanding of the metastatic process in hepatocellular carcinoma | Q34538224 | ||
| The prognostic significance of clinical and pathological features in hepatocellular carcinoma | Q34582844 | ||
| Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma | Q73984628 | ||
| Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinomas and their metastatic foci | Q74001284 | ||
| Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma | Q74001305 | ||
| Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma | Q74024736 | ||
| Absence of therapeutically relevant c-erbB-2 expression in human hepatocellular carcinomas | Q74035001 | ||
| Prognostic influence of p53 nuclear overexpression in colorectal carcinoma | Q74052868 | ||
| Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients | Q74081557 | ||
| u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma | Q74108509 | ||
| Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver | Q74172274 | ||
| Prognostic impact of P53 status in Ewing sarcoma | Q74199510 | ||
| Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma | Q74203482 | ||
| p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder | Q74327838 | ||
| Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? | Q74452571 | ||
| Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1 | Q74484550 | ||
| Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity | Q77167650 | ||
| Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence | Q77933504 | ||
| Microvessel density of hepatocellular carcinoma: its relationship with prognosis | Q77965086 | ||
| Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma | Q78076240 | ||
| Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significance. | Q53981230 | ||
| A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. | Q54058828 | ||
| p53 mutation in plasma DNA and its prognostic value in breast cancer patients | Q56765551 | ||
| Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma | Q57009239 | ||
| TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer | Q58213053 | ||
| Telomerase activity in peripheral blood for diagnosis of hepatoma | Q73144594 | ||
| Expression and possible role of ets-1 in hepatocellular carcinoma | Q73164903 | ||
| Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? | Q73180761 | ||
| Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor | Q73193733 | ||
| The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma | Q73229768 | ||
| Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma | Q73347541 | ||
| Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus | Q73370593 | ||
| Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest | Q73434301 | ||
| Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study | Q73435945 | ||
| Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma | Q73437933 | ||
| Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival | Q73444664 | ||
| The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years | Q73459311 | ||
| p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients | Q73483273 | ||
| Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival | Q73495079 | ||
| p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen | Q73505355 | ||
| Expression of p53 and p21waf1/cip1 in gastric carcinoma: lack of inter-relationship or correlation with prognosis | Q73550930 | ||
| Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers | Q73554874 | ||
| Mitotic index is the best predictive factor for survival of patients with resected hepatocellular carcinoma | Q73557173 | ||
| Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma | Q73623064 | ||
| Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma | Q73630418 | ||
| Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry | Q73672804 | ||
| Circulating tumor-derived DNA may permit the early diagnosis of head and neck squamous cell carcinomas | Q73721746 | ||
| Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer | Q73753961 | ||
| Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer | Q73773615 | ||
| Proteomic profiling from human samples: the body fluid alternative | Q73807256 | ||
| Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma | Q73821289 | ||
| Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer | Q73834088 | ||
| Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival | Q73847008 | ||
| Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma | Q73847782 | ||
| P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up | Q73880831 | ||
| Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival | Q73911275 | ||
| Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy | Q73934500 | ||
| Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis | Q35754634 | ||
| Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma. | Q36316047 | ||
| Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. | Q36316052 | ||
| Gene expression of hepatocyte growth factor and its receptor in HCC and nontumorous liver tissues | Q36396882 | ||
| Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China | Q36397234 | ||
| Expressions of ICAM-1 and its mRNA in sera and tissues of patients with hepatocellular carcinoma. | Q36397281 | ||
| Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology. | Q36397298 | ||
| Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection | Q36397376 | ||
| Polymorphism of p16INK4a gene and rare mutation of p15INK4b gene exon2 in primary hepatocarcinoma | Q36397522 | ||
| Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. | Q36492038 | ||
| Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma. | Q36618179 | ||
| Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma | Q36619741 | ||
| The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma | Q36621343 | ||
| Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors | Q36621795 | ||
| Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma | Q36622264 | ||
| Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma | Q38323147 | ||
| Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression | Q38467523 | ||
| Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies | Q39562262 | ||
| Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis | Q39585393 | ||
| Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients. | Q40694213 | ||
| Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared | Q40786571 | ||
| Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia | Q41719391 | ||
| Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients | Q41902323 | ||
| Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy | Q42102126 | ||
| Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma | Q42644303 | ||
| Clinical significance of serum intercellular adhesion molecule-1 detection in patients with hepatocellular carcinoma | Q43119012 | ||
| Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. | Q43713126 | ||
| Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer | Q43760328 | ||
| Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma. | Q43892079 | ||
| The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma | Q44103449 | ||
| 8pter-p23 deletion is associated with racial differences in prostate cancer outcome | Q44185641 | ||
| High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. | Q44281904 | ||
| The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas | Q44801395 | ||
| Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness. | Q47262968 | ||
| Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. | Q47975528 | ||
| Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver | Q47993681 | ||
| Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival | Q48749518 | ||
| Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. | Q50925177 | ||
| Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time. | Q52977312 | ||
| Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma. | Q53407989 | ||
| A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA. | Q53411281 | ||
| p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. | Q53411367 | ||
| Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis. | Q53833521 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 385-392 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | The prognostic molecular markers in hepatocellular carcinoma | |
| P478 | volume | 8 |
| Q35611503 | A decade's studies on metastasis of hepatocellular carcinoma |
| Q39711547 | A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice |
| Q36502549 | Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells |
| Q48250035 | An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib. |
| Q24803467 | Angiogenesis in male breast cancer |
| Q36496307 | Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells |
| Q94314421 | Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas |
| Q36308966 | Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma |
| Q40836748 | Brachytherapy with Iodine-125 seeds strand for treatment of main portal vein tumor thrombi: an experimental study in a rabbit model |
| Q38946743 | CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy |
| Q53236680 | Carvacrol modulates instability of xenobiotic metabolizing enzymes and downregulates the expressions of PCNA, MMP-2, and MMP-9 during diethylnitrosamine-induced hepatocarcinogenesis in rats. |
| Q58707841 | Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma |
| Q45934010 | Characteristic genotypes of vascular endothelial growth factor are susceptible to ascites in patients with cirrhosis. |
| Q95725487 | Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies |
| Q53217138 | Chemoprevention of Diethylnitrosamine-Initiated and Phenobarbital-Promoted Hepatocarcinogenesis in Rats by Sulfated Polysaccharides and Aqueous Extract of Ulva lactuca. |
| Q46690666 | Circulating matrix metalloproteinase-2 is associated with cystatin C level, posttransplant duration, and diabetes mellitus in kidney transplant recipients |
| Q39506866 | Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma. |
| Q34382605 | Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma |
| Q36178628 | Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China |
| Q35113002 | Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt |
| Q39729733 | Concanavalin A-immobilized magnetic nanoparticles for selective enrichment of glycoproteins and application to glycoproteomics in hepatocelluar carcinoma cell line |
| Q41983590 | Construction and expression of recombined human AFP eukaryotic expression vector |
| Q39768300 | Correlation between angiogenic/inflammatory mediators in Wister rat model of liver dysplasia |
| Q33973729 | Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma |
| Q40618623 | Correlation between metastatic potential and variants from colorectal tumor cell line HT-29 |
| Q36751651 | Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma |
| Q44676237 | Cross-species hybridization of woodchuck hepatitis viral infection-induced woodchuck hepatocellular carcinoma using human, rat and mouse oligonucleotide microarrays |
| Q46581010 | Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model |
| Q37702744 | DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells. |
| Q40697710 | DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line |
| Q34630291 | Decoding global gene expression programs in liver cancer by noninvasive imaging |
| Q34115719 | Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma |
| Q37386559 | Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma |
| Q33197537 | Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas |
| Q37411609 | Diagnostic Utility of ANG in Coronary Heart Disease Complicating Chronic Heart Failure: A Cross-Sectional Study |
| Q37682244 | Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile. |
| Q34029258 | Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma |
| Q33866121 | Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma |
| Q46843790 | Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis |
| Q86615477 | Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients |
| Q30921046 | Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity |
| Q36308149 | Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection |
| Q43037437 | Effect of cAMP-dependent protein kinase A (PKA) on HCV nucleocapsid assembly and degradation |
| Q42062943 | Effect of semisynthetic extracellular matrix-like hydrogel containing hepatocyte growth factor on repair of femoral neck defect in rabbits. |
| Q40428445 | Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model |
| Q40603982 | Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. |
| Q33188513 | Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells |
| Q36474677 | Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance. |
| Q37844619 | Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma |
| Q28241429 | Endostatin levels in exudative pleural effusions |
| Q39169085 | Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor |
| Q40600338 | Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway |
| Q53476365 | Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. |
| Q90383817 | Experimental Models to Define the Genetic Predisposition to Liver Cancer |
| Q33230149 | Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential |
| Q36190335 | Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma |
| Q36178311 | Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis |
| Q54694704 | Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. |
| Q36180620 | Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis |
| Q34382649 | Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis |
| Q44394234 | Expression of matrix metalloproteinases and their inhibitors in the woodchuck model of hepatocellular carcinoma |
| Q36308973 | Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues |
| Q36308484 | Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells |
| Q37230680 | Following up tumour angiogenesis: from the basic laboratory to the clinic |
| Q33194407 | From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis |
| Q39979473 | Gene expression profiles in liver of mouse after chronic exposure to drinking water |
| Q36178624 | Gene expression profiles of hepatoma cell line HLE. |
| Q36114523 | Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma |
| Q36014285 | HAX-1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation |
| Q37477526 | Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers |
| Q46652722 | Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. |
| Q89909650 | Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats |
| Q75378987 | Immunohistochemical assessment of proliferating cell nuclear antigen in primary hepatocellular carcinoma and dysplastic nodules |
| Q94220643 | In Vitro Effect of Cytokines, Inducers, and Inhibitors on the Secretion of MMP-2 and MMP-9 in Hepatocarcinoma Cell Line SK-Hep-1 |
| Q36209772 | In situ detection of TGF betas, TGF beta receptor II mRNA and telomerase activity in rat cholangiocarcinogenesis |
| Q92618951 | Inflammatory pseudotumor-like follicular dendritic cell sarcoma: a rare presentation of a hepatic mass |
| Q36308821 | Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: An experimental study |
| Q41821170 | Inhibition of telomerase activity by HDV ribozyme in cancers |
| Q43159514 | Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell |
| Q36474130 | Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection? |
| Q28201755 | Isolation of a novel member of small G protein superfamily and its expression in colon cancer |
| Q35615755 | Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. |
| Q45282568 | Macrophage colony-stimulating factor plays a pivotal role in chemically induced hepatocellular carcinoma in mice |
| Q48355658 | Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice |
| Q38441297 | Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma. |
| Q38954232 | Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression |
| Q49745178 | Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway |
| Q55025344 | MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1. |
| Q39419949 | Micronutrient Synergy in the Fight against Hepatocellular Carcinoma |
| Q58735649 | Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma |
| Q54664683 | Molecular characterization of salivary gland malignancy using the Smgb-Tag transgenic mouse model. |
| Q44249273 | Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells |
| Q92132177 | Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data |
| Q37702382 | Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways |
| Q64922344 | Olive oil polyphenols suppress the TGF-α-induced migration of hepatocellular carcinoma cells. |
| Q34016378 | Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines |
| Q43211650 | Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system |
| Q35588545 | Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma |
| Q35913323 | Oxidation of heat shock protein 60 and protein disulfide isomerase activates ERK and migration of human hepatocellular carcinoma HepG2. |
| Q45199747 | PCNA in situ hybridization: a novel and reliable tool for detection of dynamic changes in proliferative activity |
| Q39657652 | Phenolic-Containing Organic Extracts of Mulberry (Morus alba L.) Leaves Inhibit HepG2 Hepatoma Cells Through G2/M Phase Arrest, Induction of Apoptosis, and Inhibition of Topoisomerase IIα Activity |
| Q37211794 | Pituitary protein 7B2 plasma levels in patients with liver disease: Comparisons with other hormones and neuropeptides |
| Q36763380 | Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway |
| Q49135671 | Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery |
| Q35101345 | Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials |
| Q90578117 | Prognostic analysis of histopathological images using pre-trained convolutional neural networks: application to hepatocellular carcinoma |
| Q81455649 | Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study |
| Q36474101 | Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study |
| Q36936804 | Prognostic value of the Fas/Fas ligand system in breast cancer |
| Q34485591 | Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production |
| Q37338042 | Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma |
| Q33967757 | Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma |
| Q36474467 | Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma |
| Q34105179 | Role of lifeguard β-isoform in the development of breast cancer |
| Q39470843 | Roles for rat hepatocyte malignant transforming factor (HMTF) in late stage of hepatocarcinogenesis |
| Q35668936 | Roles of main pro- and anti-angiogenic factors in tumor angiogenesis |
| Q62734450 | Schistosoma mansoni Egg-Secreted Antigens Activate Hepatocellular Carcinoma-Associated Transcription Factors c-Jun and STAT3 in Hamster and Human Hepatocytes |
| Q83223962 | Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2'-deoxycytidine |
| Q36961950 | Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients |
| Q36537224 | Serum/Plasma depletion with chicken immunoglobulin Y antibodies for proteomic analysis from multiple Mammalian species. |
| Q35165994 | Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues |
| Q28081265 | Staging of hepatocellular carcinoma |
| Q34322940 | Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma |
| Q39879199 | Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition |
| Q84509671 | Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification |
| Q42695569 | Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro |
| Q36178548 | Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice |
| Q28077283 | Targeting Hepatocellular Carcinoma: What did we Discover so Far? |
| Q38806970 | The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma |
| Q53228986 | The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. |
| Q36209697 | The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F. |
| Q33911063 | The regulation of non-coding RNA expression in the liver of mice fed DDC. |
| Q35782195 | The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy |
| Q33977054 | The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes |
| Q42031076 | Transplantable subcutaneous hepatoma 22a affects functional activity of resident tissue macrophages in periphery |
| Q34700446 | Tumor angiogenesis after heated lipiodol infusion via the hepatic artery in a rabbit model of VX2 liver cancer |
| Q28389231 | Tumor suppressor and hepatocellular carcinoma |
| Q42376719 | Ubiquitin Associated Protein 2-Like (UBAP2L) Overexpression in Patients with Hepatocellular Carcinoma and its Clinical Significance. |
| Q59808241 | Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas |
| Q53608157 | Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats. |
| Q36502592 | Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. |
| Q37542814 | Viral hepatitis status does not affect survival in patients with hepatocellular carcinoma |
| Q48105535 | miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma. |
| Q38175875 | microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma |
| Q37420848 | p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma |
| Q42113747 | p62 Expression in primary carcinomas of the digestive system |
Search more.